Cellectar Biosciences (CLRB) Notes Payables (2010 - 2026)
Cellectar Biosciences (CLRB) posted Notes Payables of $226000.0 for Q4 2025, down 71.81% sequentially from $801650.0 in Q3 2025, and down 86.85% YoY from $1.7 million in Q4 2024.
Cellectar Biosciences (CLRB) Notes Payables (2010 - 2026) Analysis & Trends
Cellectar Biosciences has reported Notes Payables for 14 years, with the latest figure at $226000.0 in Q4 2025.
- Quarterly Notes Payables fell 86.85% year-over-year to $226000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $226000.0 (down 86.85% YoY) and the FY2025 annual result came in at $226000.0, down 86.85% from the prior year.
- Notes Payables fell to $226000.0 in Q4 2025 per CLRB's latest filing, from $801650.0 in the prior quarter.
- Over five years, Notes Payables peaked at $22.0 million in Q3 2023 and troughed at $226000.0 in Q4 2025.
- A 4-year average of $6.7 million and a median of $3.6 million in 2022 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2023 and 2025: Notes Payables jumped 3560.9% in 2023, then plunged 93.28% in 2025.
- Over 4 years, Notes Payables stood at $6.0 million in 2022, then surged by 169.93% to $16.1 million in 2023, then slumped by 89.34% to $1.7 million in 2024, then plunged by 86.85% to $226000.0 in 2025.
- According to Business Quant data, Notes Payables over the past three periods registered $226000.0, $801650.0, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cellectar Biosciences | 6.73 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17,000.00 |
| Dec 31, 2025 | 226,000.00 |
| Sep 30, 2025 | 801,650.00 |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 1.72 Mn |
| Sep 30, 2024 | 11.93 Mn |
| Jun 30, 2024 | 8.63 Mn |
| Mar 31, 2024 | 21.08 Mn |
| Dec 31, 2023 | 16.12 Mn |
| Sep 30, 2023 | 21.97 Mn |
| Jun 30, 2023 | 6.54 Mn |
| Mar 31, 2023 | 4.58 Mn |
| Dec 31, 2022 | 5.97 Mn |
| Sep 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 900,000.00 |
| Mar 31, 2022 | 2.70 Mn |
| Jun 30, 2019 | 46,000.00 |
| Mar 31, 2019 | 47,000.00 |
| Dec 31, 2018 | 43,000.00 |